Blood purification adsorption therapy is indispensable for treating renal failure, liver failure, sepsis, and autoimmune diseases. This study tackles the challenge of achieving precise, highly efficient removal of trace pathogenic toxins, aiming to establish a foundation for novel precision adsorbents. Research encompasses: (i) surface modification for blood-compatible and biocompatible interfaces; (ii) site-directed immobilization of multivalent nanobodies; and (iii) construction of interventional devices.
Key achievements: (1) A tannic‑acid‑based universal surface modification strategy was developed for hydrophilic and hydrophobic materials, along with high‑density, extended hyaluronic acid brushes. These modifications improved non‑specific fouling resistance and blood compatibility, provided abundant reactive sites, and enabled highly selective recognition of trace targets in plasma. (2) Site‑directed aldehyde modification of proteins was realized via immobilized formylglycine‑generating enzyme with in situ cofactor regeneration under continuous flow, ensuring efficient and stable catalysis. Moreover, highly efficient nucleophilic carbon coupling using Meldrum's acid and pyrazolone was established for site‑specific conjugation of aldehyde‑modified proteins, achieving single, homo‑biconjugation, and hetero‑biconjugation. This approach exhibited 2–3 orders of magnitude higher efficiency than conventional oxime/hydrazone ligation, while retaining 100% protein structure and activity. (3) Integrating the surface modification and nanobody immobilization technologies, we fabricated interventional devices that removed over 85% of inflammatory cytokines (picogram‑to‑milligram levels) from whole blood. The first nanobody‑based interleukin‑6 adsorption column was successfully produced, passing national animal safety, hemocompatibility, biosafety, and registration inspections. Feasibility clinical trials were completed, and the device is now in a nationwide multicenter confirmatory trial. Preliminary results show promising therapeutic efficacy in suppressing cytokine storms and treating sepsis.